The serum concentration of Atorvastatin can be increased when it is combined with Nelfinavir. The serum concentration of Atorvastatin can be increased when it is combined with Trandolapril. The risk or severity of adverse effects can be increased when Loratadine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Luliconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Etravirine. The risk or severity of adverse effects can be increased when Niguldipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sertaconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Diazepam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tetracycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fendiline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Abafungin is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium oxide. Atorvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Insulin Human. The serum concentration of Edoxaban can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 1,10-Phenanthroline. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rucaparib is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The serum concentration of Atorvastatin can be increased when it is combined with Geldanamycin. The risk or severity of adverse effects can be increased when Lidocaine is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Pioglitazone. The serum concentration of Atorvastatin can be increased when it is combined with S-3304. The serum concentration of Atorvastatin can be increased when it is combined with Vildagliptin. The serum concentration of Atorvastatin can be decreased when it is combined with Dabrafenib. The risk or severity of adverse effects can be increased when Clomifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Enasidenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Atorvastatin. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Mifepristone. The serum concentration of Atorvastatin can be increased when it is combined with Asunaprevir. The risk or severity of adverse effects can be increased when Daunorubicin is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Flunarizine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Paritaprevir. The risk or severity of adverse effects can be increased when Mibefradil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levosalbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lacidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin. Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Pergolide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The risk or severity of adverse effects can be increased when Primaquine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fentanyl is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Delanzomib. The metabolism of Atorvastatin can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Sulconazole is combined with Atorvastatin. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Phosphoramidon. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Clemastine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Temsirolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Telithromycin. The serum concentration of Atorvastatin can be increased when it is combined with Saquinavir. The serum concentration of Atorvastatin can be decreased when it is combined with Brigatinib. The risk or severity of adverse effects can be increased when Nilotinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Elafin. The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Dicoumarol. The risk or severity of adverse effects can be increased when Hydralazine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Quinupristin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Rilpivirine. Atorvastatin may increase the hypoglycemic activities of Glipizide. The risk or severity of adverse effects can be increased when Kitasamycin is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Warfarin. The risk or severity of adverse effects can be increased when Tesmilifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troglitazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Testosterone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lopinavir. The serum concentration of Atorvastatin can be increased when it is combined with Chymostatin. The risk or severity of adverse effects can be increased when Ketazolam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Benidipine is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Amiodarone. The risk or severity of adverse effects can be increased when Elbasvir is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rabeprazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Simvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ifosfamide is combined with Atorvastatin. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Buprenorphine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glimepiride. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatril. The risk or severity of adverse effects can be increased when Azimilide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clotrimazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clevidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The serum concentration of Aliskiren can be increased when it is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glibornuride. The serum concentration of Atorvastatin can be decreased when it is combined with Almasilate. The risk or severity of adverse effects can be increased when Clozapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ticlopidine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lisuride is combined with Atorvastatin. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ranitidine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Pentobarbital. The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole. Atorvastatin may increase the hypoglycemic activities of Insulin Pork. The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Conivaptan is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 4-(2-Aminoethyl)Benzenesulfonyl Fluoride. The risk or severity of adverse effects can be increased when Clofazimine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliclazide. The risk or severity of adverse effects can be increased when Pinaverium is combined with Atorvastatin. The serum concentration of Naloxegol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sirolimus is combined with Atorvastatin. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Simeprevir. The serum concentration of Nintedanib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dalfopristin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Solithromycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Glycerol Phenylbutyrate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lovastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziprasidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nilvadipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The risk or severity of adverse effects can be increased when Azelnidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat.